Covid-19 update: Hetero Healthcare Ltd starts supply of generic Remdesivir
Hetero Healthcare Ltd is supplying 60,000 vials of
Covifor, generic version of Remdesivir injection in the country from July 13 to
20, the company website said.
Covifor
is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and
children, hospitalised with severe symptoms of the disease.
The drug
is available in 100 mg vial (Injectable).
It needs
to be administered intravenously in a hospital, critical care setting, under
the supervision of a registered medical practitioner.
Out of
60,000 vials, Maharashtra, which has the highest number of COVID-19 cases in
the country will get 12,500 followed by Delhi and Telangana with 10,000 and
9,000 respectively.
According
to the website, Tamil Nadu, Gujarat, Andhra Pradesh and Karnataka will get
7500, 6000, 2000 and 3000 respectively while the rest of the country will get
10,000 injections. Read More
Comments
Post a Comment